Combined chemotherapy and intra-arterial chemotherapy of retinoblastoma |
Choi, Saerom
(Division of Pediatric Hematology and Oncology, Department of Pediatrics, Yonsei University Health System)
Han, Jung Woo (Division of Pediatric Hematology and Oncology, Department of Pediatrics, Yonsei University Health System) Kim, Hyosun (Division of Pediatric Hematology and Oncology, Department of Pediatrics, Yonsei University Health System) Kim, Beom Sik (Division of Pediatric Hematology and Oncology, Department of Pediatrics, Yonsei University Health System) Kim, Dong Joon (Department of Radiology, Yonsei University Health System) Lee, Sung Chul (Department of Ophthalmology, Yonsei University Health System) Lyu, Chuhl Joo (Division of Pediatric Hematology and Oncology, Department of Pediatrics, Yonsei University Health System) |
1 | Dunkel IJ. Retinoblastoma. In: 42nd Annual Meeting of American Society of Clinical Oncology; 2006 Jun 2-6; Atlanta, USA. Alexandria; American Society of Clinical Oncology; 2006:6;591-4. |
2 | Abramson DH, Marr BP, Brodie SE, Dunkel I, Palioura S, Gobin YP. Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review. PLoS One 2012;7:e34120. DOI |
3 | Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002;133:657-64. DOI |
4 | Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol 2011;129:732-7. DOI |
5 | Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors. J Neurosurg 2011;114:1603-8. DOI |
6 | Uusitalo MS, Van Quill KR, Scott IU, Matthay KK, Murray TG, O'Brien JM. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol 2001;119:41-8. |
7 | Atchaneeyasakul LO, Wongsiwaroj C, Uiprasertkul M, Sanpakit K, Thephamongkhol K, Trinavarat A. Prognostic factors and treatment outcomes of retinoblastoma in pediatric patients: a single-institution study. Jpn J Ophthalmol 2009;53:35-9. DOI |
8 | Parulekar MV. Retinoblastoma: current treatment and future direction. Early Hum Dev 2010;86:619-25. DOI |
9 | Nichols KE, Walther S, Chao E, Shields C, Ganguly A. Recent advances in retinoblastoma genetic research. Curr Opin Ophthalmol 2009;20:351-5. DOI |
10 | Shields CL, Shields JA. Diagnosis and management of retinoblastoma. Cancer Control 2004;11:317-27. DOI |
11 | Kim J, Do H, Egbert P. Enucleated eyes after failed intra-arterial infusion of chemotherapy for unilateral retinoblastoma: histopathologic evaluation of vitreous seeding. Clin Ophthalmol 2011;5:1655-8. |
12 | Khetan V, Gupta A, Gopal L. Retinoblastoma: recent trends A mini review based on published literature. Oman J Ophthalmol 2011;4:108-15. DOI |
13 | Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Naduvilath TJ. Chemoreduction for unilateral retinoblastoma. Arch Ophthalmol 2002;120:1653-8. DOI |
14 | Shields CL, Kaliki S, Shah SU, Bianciotto CG, Jabbour P, Shields JA. Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment. Retina 2012;32:799-804. DOI |
15 | Klufas MA, Gobin YP, Marr B, Brodie SE, Dunkel IJ, Abramson DH. Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization. AJNR Am J Neuroradiol 2012;33:1608-14. DOI |
16 | Honavar SG, Singh AD, Shields CL, Meadows AT, Demirci H, Cater J, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol 2002;120:923-31. DOI |
17 | Kaliki S, Shields CL, Shah SU, Eagle RC Jr, Shields JA, Leahey A. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma. Arch Ophthalmol 2011;129:1422-7. DOI |
18 | Bianciotto C, Shields CL, Iturralde JC, Sarici A, Jabbour P, Shields JA. Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma. Ophthalmology 2012;119:843-9. DOI |
19 | Shields CL, Bianciotto CG, Jabbour P, Griffin GC, Ramasubramanian A, Rosenwasser R, et al. Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications. Arch Ophthalmol 2011;129:1407-15. DOI |
20 | Venturi C, Bracco S, Cerase A, Cioni S, Galluzzi P, Gennari P, et al. Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments. Acta Ophthalmol 2012 Jan 23 [Epub]. http://dx.doi.org/10.1111/j.1755-3768.2011.02296.x. |